Page 2 - Graf Acquisition Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Graf acquisition corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Graf Acquisition Corp Today - Breaking & Trending Today

Graf Acquisition IV : Unaudited Condensed Consolidated Financial Statements - Form 8-K -October 05, 2023 at 05:16 pm EDT

Unaudited Condensed Consolidated Financial Statements

Condensed Balance Sheets as of June 30, 2023 . ....

United States , South Korea , Republic Of Korea , Affimed Gmbh , Company Information , Nasdaq Stock Market , Exchange Commission , Graf Acquisition Corp , Party Convertible , Nkgen Operating Biotech Inc References , Exchange Ratio , Party Transactions , Short Term Related Party Loan , Nkgen Operating Biotech Inc , Co Ltd , European Union , Party Loan , Austria Merger Sub Inc , Sp Global Inc , Nkgen Biotech Inc , Company Related Party , Balance Sheets , Condensed Statements , Six Months Ended June , Condensed Consolidated Statements , Stockholder Deficit ,

NKGen Biotech, Inc. Announces Closing of Business Combination

NKGen Biotech, Inc. Announces Closing of Business Combination
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Denise Chua , James Graf , Nkgen Biotech Inc , Graf Acquisition Corp , Chris Calabresemanaging Directorlifesci Advisors , Corporate Communicationsnkgen Biotech Inc , Globe Newswire Nkgen Biotech Inc , Kevin Gardnermanaging Directorlifesci Advisors , Exchange Commission , Graf Acquisition , Nasdaq Global Market , Nasdaq Capital Market , Interim Chief Financial , Interim Chief Financial Officer , Santa Ana , Vice President , Investor Relations , Gardnermanaging Directorlifesci Advisors ,

Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 25, 2023

THE WOODLANDS, Texas, Sept. 22, 2023 /PRNewswire/ Graf Acquisition Corp. IV , announced today that on September 20, 2023, it adjourned, without conducting any business, the special meeting of. ....

United States , Kevin Gardner , Denise Chua , Chris Calabrese , Sabrina Mckee , Lifesci Advisors , Company Or Graf , Nkgen Biotech Inc , Graf Acquisition Corp , Exchange Commission , Prnewswire Graf Acquisition Corp , Corporate Communications , Morrow Sodali , Special Meeting , Business Combination , Definitive Proxy , Santa Ana , Registration Statement , Graf Acquisition , Blanding Blvd , Securities Act , Investor Relations , Financial Officer , Sci Advisors ,

Graf Acquisition Corp. IV Announces Adjournment of Special Meeting to Approve Business Combination with NKGen Biotech, Inc. to September 13, 2023

/PRNewswire/ Graf Acquisition Corp. IV (NYSE: GFOR, GFOR.U, GFOR WS) (the "Company" or "Graf"), announced today that on September 8, 2023, it adjourned,. ....

United States , Chris Calabrese , Kevin Gardner , Sabrina Mckee , Denise Chua , Graf Industrial Corp , Lifesci Advisors , Corporate Communications , Graf Acquisition Corp , Morrow Sodali , Company Or Graf , Exchange Commission , Prnewswire Graf Acquisition Corp , Nkgen Biotech Inc , Special Meeting , Business Combination , Santa Ana , Registration Statement , Graf Acquisition , Blanding Blvd , Securities Act , Looking Statements , Investor Relations , Financial Officer , Sci Advisors , Graf Industrial Corp ,

NKGen Biotech, Inc. Announces First Patient Dosed in Phase I Clinical Trial of SNK02, Allogeneic NK Cell Therapy Product Candidate, for the Treatment of Solid Tumors

NKGen Biotech, Inc. Announces First Patient Dosed in Phase I Clinical Trial of SNK02, Allogeneic NK Cell Therapy Product Candidate, for the Treatment of Solid Tumors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Chris Calabrese , Sabrina Mckee , Kevin Gardner , Denise Chua , Graf Acquisition Corp , Drug Administration , Corporate Communications , Lifesci Advisors , Globe Newswire Nkgen Biotech Inc , Nkgen Biotech Inc , Exchange Commission , Announces First Patient Dosed , Phasei Clinical Trial , Therapy Product Candidate , Investigational New Drug , Graf Acquisition , Santa Ana , Registration Statement , Blanding Blvd , Securities Act , Investor Relations , Financial Officer , Sci Advisors ,